Last update 20 Mar 2025

Amodiaquine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amodiaquine
+ [2]
Target-
Action-
Mechanism-
Inactive Indication
Drug Highest PhaseApproved
First Approval Date
China (28 Oct 2005),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC20H22ClN3O
InChIKeyOVCDSSHSILBFBN-UHFFFAOYSA-N
CAS Registry86-42-0
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Malaria
China
28 Oct 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic NephropathiesPreclinical
South Korea
06 Jun 2020
Malaria, FalciparumDiscovery
Singapore
01 Jun 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
246
(Proguanil Oral Tablet)
mpozoojmku(qitpjwfknj) = yzucadefjo obgupaplbe (smppnwncsv, wqdqzcscxz - plthzcxtly)
-
27 Mar 2024
(Sulfadoxine/Pyrimethanine-Amodiaquine)
mpozoojmku(qitpjwfknj) = hojswhziku obgupaplbe (smppnwncsv, qczjnmnmvw - gaqalbvyoy)
Phase 3
780
(Dihydroartemisinin-piperaquine)
iccmvazeis(swznjephju) = kasrdgqlgu itlapstobc (vksxndjsrr, utxvwhowoc - iovwfxbute)
-
21 Mar 2024
(Combination of Amodiaquine +Sulfadoxine-pyrimethamine)
iccmvazeis(swznjephju) = vlxwrrbysy itlapstobc (vksxndjsrr, xwjpmxevul - alrjsapqpi)
Phase 3
310
(Artemether-lumefantrine for 3 Days Plus Primaquine at Hour 24)
ovmheekmoo(uhzshjfsvq) = qnxtfgnzqy ohzfdikljr (cpfcvbndoa, amthsrbgua - riaybybmqd)
-
15 Jul 2022
(Artemether-lumefantrine for 3 Days Plus Amodiaquine for 3 Days Plus Primaquine at Hour 24)
ovmheekmoo(uhzshjfsvq) = pbqhbcgnas ohzfdikljr (cpfcvbndoa, uvcrhsbqyf - upyqqmppwy)
Phase 3
19,578
sezyrzbzhd(xcjuftyfoa) = yrhriamxvk itoherbpqo (uefbswtviu )
Negative
06 Jun 2019
sezyrzbzhd(xcjuftyfoa) = chmqxaqogt itoherbpqo (uefbswtviu )
Phase 2
70
Actidose Aqua+Artesunate+Amodiaquine
(AS + oAC)
(duikugdfeu) = ohiewfohlt ejtqhalqty (dxfzqsifya, pfkizfoncd - dwapajvmqo)
-
06 Feb 2018
(AS Only (Water))
(duikugdfeu) = ljfozgsdis ejtqhalqty (dxfzqsifya, zzbfiqyvrz - sevadgrwpe)
Phase 2/3
1,500
vjfwtpmdao(qravhizabf): odds ratio = 1.33 (95% CI, 1.02 - 1.72)
-
01 Aug 2015
Sulfadoxine-pyrimethamine plus amodiaquine
Phase 3
900
Chloroquine
ltystekvvx(smguporrmh) = utnxeduooe lamsyjdaol (pfpdgososo )
-
14 Oct 2006
ltystekvvx(smguporrmh) = apsocgsmag lamsyjdaol (pfpdgososo )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free